Usage: CYMBALTA® is indicated for the treatment of major depressive disorder, generalized anxiety disorder (in adults and children 7+), diabetic peripheral neuropathic pain, fibromyalgia (in adults and those 13+), and chronic musculoskeletal pain in adults.
Usage: Duloxetine delayed-release capsules are indicated for treating major depressive disorder, generalized anxiety disorder (in adults and children 7+), diabetic peripheral neuropathic pain, fibromyalgia (in individuals 13+), and chronic musculoskeletal pain in adults.
Usage: Duloxetine delayed-release capsules are indicated for treating major depressive disorder, generalized anxiety disorder (in adults and children 7+), diabetic peripheral neuropathic pain, fibromyalgia (in patients 13+), and chronic musculoskeletal pain in adults.
Usage: Duloxetine delayed-release capsules are indicated for the treatment of major depressive disorder, generalized anxiety disorder, diabetic peripheral neuropathic pain, fibromyalgia, and chronic musculoskeletal pain in adults and certain pediatric patients.
Usage: HUMALOG Mix75/25 is indicated for improving glycemic control in adults with diabetes mellitus. It has fixed proportions of rapid-acting and intermediate-acting insulins, limiting adjustments for basal and prandial doses.
Usage: HUMALOG Mix50/50 is indicated for improving glycemic control in adults with diabetes mellitus. However, it has limitations as the fixed proportions of rapid-acting and intermediate-acting insulins prevent adjustments for basal and prandial dosing.